Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mature Pseudomonas aeruginosa biofilms prevail compared to young biofilms in the presence of ceftazidime.

Literature DB >> 22777043

Mature Pseudomonas aeruginosa biofilms prevail compared to young biofilms in the presence of ceftazidime.

Laura L Bowler¹, George G Zhanel, T Blake Ball, Laura L Saward.

Abstract

Phenotypic tolerances to antibiotics of mature and young Pseudomonas aeruginosa PAO1 biofilms and released planktonic bacteria were compared for four antibiotics. Resistance levels were similar for gentamicin and ciprofloxacin but differed for ceftazidime and meropenem. β-Lactamase mapping showed that, after 5 h of ceftazidime exposure, mature biofilms produced more β-lactamase than young biofilms, facilitating the growth of released planktonic bacteria. This shows the importance of early treatment and choice of antibiotics for P. aeruginosa biofilm infections.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2012 PMID： 22777043 PMCID： PMC3421884 DOI： 10.1128/AAC.00650-12

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

14 in total

Review 1. Antibiotic resistance of bacteria in biofilms.

Authors: P S Stewart; J W Costerton
Journal: Lancet Date: 2001-07-14 Impact factor: 79.321

2. Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein protein interactions.

Authors: André Galarneau; Martin Primeau; Louis-Eric Trudeau; Stephen W Michnick
Journal: Nat Biotechnol Date: 2002-06 Impact factor: 54.908

3. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms.

Authors: T R De Kievit; M D Parkins; R J Gillis; R Srikumar; H Ceri; K Poole; B H Iglewski; D G Storey
Journal: Antimicrob Agents Chemother Date: 2001-06 Impact factor: 5.191

4. A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead.

Authors: T J Marrie; J Nelligan; J W Costerton
Journal: Circulation Date: 1982-12 Impact factor: 29.690

5. Randomized trial of ceftazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosis.

Authors: R Gold; S Carpenter; H Heurter; M Corey; H Levison
Journal: J Pediatr Date: 1987-12 Impact factor: 4.406

6. beta-Lactam coselection of sensitive and TEM-1 beta-lactamase-producing subpopulations in heterogeneous Escherichia coli colonies.

Authors: F Baquero; M F Vicente; J C Pérez-Diaz
Journal: J Antimicrob Chemother Date: 1985-02 Impact factor: 5.790

7. Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa.

Authors: N Masuda; S Ohya
Journal: Antimicrob Agents Chemother Date: 1992-09 Impact factor: 5.191

8. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance.

Authors: Thien-Fah Mah; Betsey Pitts; Brett Pellock; Graham C Walker; Philip S Stewart; George A O'Toole
Journal: Nature Date: 2003-11-20 Impact factor: 49.962

9. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production.

Authors: Niels Bagge; Martin Schuster; Morten Hentzer; Oana Ciofu; Michael Givskov; Everett Peter Greenberg; Niels Høiby
Journal: Antimicrob Agents Chemother Date: 2004-04 Impact factor: 5.191

10. Dynamics and spatial distribution of beta-lactamase expression in Pseudomonas aeruginosa biofilms.

Authors: Niels Bagge; Morten Hentzer; Jens Bo Andersen; Oana Ciofu; Michael Givskov; Niels Høiby
Journal: Antimicrob Agents Chemother Date: 2004-04 Impact factor: 5.191

15 in total

1. Glutathione-Disrupted Biofilms of Clinical Pseudomonas aeruginosa Strains Exhibit an Enhanced Antibiotic Effect and a Novel Biofilm Transcriptome.

Authors: William Klare; Theerthankar Das; Amaye Ibugo; Edwina Buckle; Mike Manefield; Jim Manos
Journal: Antimicrob Agents Chemother Date: 2016-07-22 Impact factor: 5.191

2. Eravacycline (TP-434) is active in vitro against biofilms formed by uropathogenic Escherichia coli.

Authors: Trudy H Grossman; William O'Brien; Kathryn O Kerstein; Joyce A Sutcliffe
Journal: Antimicrob Agents Chemother Date: 2015-01-26 Impact factor: 5.191

3. Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa.

Authors: Sandra Mikhail; Nivedita B Singh; Razieh Kebriaei; Seth A Rice; Kyle C Stamper; Mariana Castanheira; Michael J Rybak
Journal: Antimicrob Agents Chemother Date: 2019-07-25 Impact factor: 5.191

4. An In Vitro Model of Nonattached Biofilm-Like Bacterial Aggregates Based on Magnetic Levitation.

Authors: Pavel Domnin; Anastasiya Arkhipova; Stanislav Petrov; Elena Sysolyatina; Vladislav Parfenov; Pavel Karalkin; Andrey Mukhachev; Alexey Gusarov; Mikhail Moisenovich; Yusef Khesuani; Svetlana Ermolaeva
Journal: Appl Environ Microbiol Date: 2020-09-01 Impact factor: 4.792

9. Efficacy of Linezolid and Fosfomycin in Catheter-Related Biofilm Infection Caused by Methicillin-Resistant Staphylococcus aureus.

Authors: Dong Chai; Xu Liu; Rui Wang; Yan Bai; Yun Cai
Journal: Biomed Res Int Date: 2016-06-05 Impact factor: 3.411

10. Individual and Combined Effects of Engineered Peptides and Antibiotics on Pseudomonas aeruginosa Biofilms.

Authors: Biswajit Mishra; Guangshun Wang
Journal: Pharmaceuticals (Basel) Date: 2017-06-25